Last reviewed · How we verify

NCT06049628

The Impact of FIFA 11+ on Isokinetic Muscle Strength and Balance

Completed NA Last updated 22 September 2023
What this trial tests

NA trial testing FIFA 11+ exercise program in Injury Prevention in 24 participants. Completed in 30 December 2019.

Timeline
1 April 2019
Primary endpoint
1 April 2019
30 December 2019

Quick facts

Lead sponsorYeditepe University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment24
Start date1 April 2019
Primary completion1 April 2019
Estimated completion30 December 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Yeditepe University

Who can join

Adults 15 to 18, male only, with Injury Prevention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

FIFA 11+ program; It consists of simple, easily remembered, and time-consuming, sport-specific exercises underlying fair play. Although the FIFA 11+ program is a well-established warm-up protocol for injury prevention among football players, the performance improvement aspect of the program is not often discussed in the literature. The study's objective is to investigate the efficacy of the FIFA 11+ program on sports performance parameters such as dynamic balance, isokinetic muscle strength performance in adolescent amateur male football players.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Injury Prevention

Currently open trials in the same condition.

Other Yeditepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06049628.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing